Related Experiment Videos
Betulinic acid derivatives as anticancer agents: structure activity relationship
Rama Mukherjee1, Vivek Kumar, Sanjay K Srivastava
1Medicinal Chemistry, Dabur Research Foundation, 22 Site IV, Sahibabad, Ghaziabad 201010, UP, India.
Anti-Cancer Agents in Medicinal Chemistry
|May 23, 2006
Summary
Betulinic acid derivatives show potent anticancer activity by inducing apoptosis. Structural modifications, particularly at C-28 and C-2, enhance cytotoxicity, offering a new molecular skeleton for drug design.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Betulinic acid, a pentacyclic triterpene, exhibits diverse biological activities, notably anticancer and anti-HIV properties.
- Its anticancer mechanism involves inducing apoptosis, independent of p53 status, and its favorable safety profile encourages structural modifications.
Purpose of the Study:
- To review structure-activity relationships (SAR) of betulinic acid derivatives modified at various positions (C-1, C-2, C-3, C-4, C-20, C-28, A, D, E rings).
- To identify key structural features responsible for enhanced anticancer potency and efficacy.
Main Methods:
- Compilation and analysis of SAR studies on chemically modified betulinic acid derivatives.
- Screening of derivatives for anticancer activity based on structural variations.
Main Results:
- The C-28 carboxylic acid moiety is crucial for cytotoxicity.
- Halo substituents at the C-2 position significantly enhance cytotoxicity.
- Ester functionalities at the C-3 position generally improve cytotoxicity, though not universally.
- The A, B, and C ring system is important for anticancer activity.
Conclusions:
- Betulinic acid derivatives represent a promising scaffold for novel anticancer drug development.
- Targeted modifications at specific positions can significantly optimize anticancer potency and efficacy.